PHI with Maxillary sinusitis
How does this condition affect your private health insurance?
Kieferhöhlenvereiterung, or maxillary sinusitis, is an inflammation and infection of the air-filled cavities located within the cheekbones. It commonly arises as a complication of viral upper respiratory tract infections, like a common cold, which can then lead to bacterial superinfection. Symptoms include significant facial pain and pressure, especially below the eyes, headache, nasal congestion, and often thick, discolored nasal discharge. Fever and a reduced sense of smell are also common. The condition occurs when the sinus openings become blocked, trapping mucus and creating a breeding ground for pathogens. Diagnosis is typically clinical, with treatment focused on relieving symptoms, clearing infection with antibiotics if bacterial, and improving sinus drainage to prevent chronicity.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
1 to 4 weeks for acute cases
Duration of Illness (Lifetime)
Typically a one-time event; can be recurrent or chronic, lasting over 12 weeks for chronic forms.
Cost of Treatment (Initial)
Approximately 50 to 500 EUR, depending on severity and need for specialist consultation or imaging.
Cost of Treatment (Lifetime)
50 to 2000+ EUR, depending on recurrence, chronicity, and need for repeated treatments or surgical interventions.
Mortality Rate
Extremely low (<0.01%), primarily in very rare cases of severe complications like intracranial spread.
Risk of Secondary Damages
Low (5-15%), including chronic sinusitis, orbital cellulitis (rare), meningitis (extremely rare), or persistent facial pain.
Probability of Full Recovery
High (>90%) for acute cases with appropriate treatment.
Underlying Disease Risk
Moderate (20-40%), often triggered by viral upper respiratory infections; predisposed by allergies, nasal polyps, or anatomical variations like a deviated septum.